Valeria Levitin
Family Medicine · Des Plaines, ILNPI 1104937515
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,604 and has fallen 98.7% since, to $21 in 2023.
Across 124 payments — averaging $20.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$591
- Amarin Pharma, Inc.$271
- Merck$235
- Boehringer Ingelheim$235
- Amneal Pharmaceuticals LLC$221
- Mannkind Corporation$142
- plus $892 from 23 others
What the payments were for
- Food & beverage$2,581100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 18 | $591 |
| Amarin Pharma, Inc. | 10 | $271 |
| Merck | 15 | $235 |
| Boehringer Ingelheim | 12 | $235 |
| Amneal Pharmaceuticals LLC | 14 | $221 |
| Mannkind Corporation | 13 | $142 |
| Shire North American Group Inc | 6 | $124 |
| AstraZeneca | 1 | $89 |
| Sanofi-aventis U.S. LLC | 5 | $76 |
| IBSA Pharma Inc. | 5 | $72 |
| Pfizer | 1 | $67 |
| Valeritas, Inc. | 3 | $63 |
| AbbVie | 2 | $41 |
| Lilly USA, LLC | 2 | $38 |
| Spineology Inc. | 1 | $35 |
| Corcept Therapeutics | 2 | $34 |
| Abbott | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Avanir Pharmaceuticals, Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Trevena, Inc. | 1 | $21 |
| Insulet Corporation | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Amgen | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Novartis | 1 | $14 |
| Astellas Pharma US Inc | 1 | $13 |
| Tandem Diabetes Care, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,587 in reported general payments places this provider in the 85th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Des Plaines
- Nigam PatelDes Plaines$34K
- Inder SinghDes Plaines$20K
- Frank PhillipsChicago$1.6M
- Peter TothSterling$1.4M
- Bradley TorphyChicago$1.3M
- Jeffrey RoyceRockford$890K
- Anthony AuriemmaWestmont$788K
- Manfred ManGurnee$764K
- Barbara BellarOakbrook Terrace$599K
- Bernie RancheroAltamont$533K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.